New hope for dialysis patients who can't use standard blood thinners
Disease control
Recruiting now
This study tests a drug called Niyad as a blood thinner for people with acute kidney injury who need continuous dialysis but cannot use the standard drug heparin or are at high risk for bleeding. About 70 participants will receive either Niyad or a placebo to see if it safely pre…
Phase: NA • Sponsor: Talphera, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC